Cargando…
Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis
Osteoarthritis is a common cause of lameness in horses, resulting in poor performance. Intra-articular platelet-rich plasma can deliver a collection of bioactive molecules, such as autologous growth factors and proteins involved in the quality of tissue repair. Horses (n=5) with osteoarthritis affec...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556911/ https://www.ncbi.nlm.nih.gov/pubmed/31170778 http://dx.doi.org/10.4102/jsava.v90i0.1721 |
_version_ | 1783425384260304896 |
---|---|
author | Smit, Yolandi Marais, Hendrik J. Thompson, Peter N. Mahne, Arnold T. Goddard, Amelia |
author_facet | Smit, Yolandi Marais, Hendrik J. Thompson, Peter N. Mahne, Arnold T. Goddard, Amelia |
author_sort | Smit, Yolandi |
collection | PubMed |
description | Osteoarthritis is a common cause of lameness in horses, resulting in poor performance. Intra-articular platelet-rich plasma can deliver a collection of bioactive molecules, such as autologous growth factors and proteins involved in the quality of tissue repair. Horses (n=5) with osteoarthritis affecting antebrachiocarpal, middle carpal or metacarpophalangeal joints, and horses (n=5) without osteoarthritis of the corresponding joints (radiographically free of osteoarthritis), were used for the production of platelet-rich plasma which was subsequently injected into selected joints. Clinical and synovial fluid changes after intra-articular injection of platelet-rich plasma as well as synovial platelet-derived growth factor-BB and transforming growth factor-beta 1 concentration changes were evaluated in these joints and compared between normal joints and joints with osteoarthritis. A gravity filtration system produced a moderately concentrated platelet-rich plasma, representing a 4.7-fold increase in baseline platelet concentration. The synovial effusion score was significantly different between the control joints and joints with osteoarthritis on Day 0 with a higher score in the group with osteoarthritis. Within the control group, the synovial effusion score was significantly higher on Days 1 and 2 compared to Day 0. For both groups, the synovial fluid nucleated cell count, predominantly intact neutrophils, was significantly increased on Days 1 and 2, with no significant difference between groups. The mean synovial platelet-derived growth factor-BB and transforming growth factor-beta 1 concentrations were increased for both groups but significantly lowered in the group with osteoarthritis on Day 1 compared to normal joints. Concentrations for platelet-derived growth factor-BB remained unchanged on Day 5, compared to Day 1, with no significant difference between groups. In conclusion, intra-articular treatment with platelet-rich plasma resulted in increased synovial growth factor concentrations in joints but with lower concentrations in joints with osteoarthritis. A transient inflammatory reaction was seen both clinically as an increase in synovial effusion and cytologically in both normal joints and joints with osteoarthritis. KEYWORDS: horse; osteoarthritis; platelet-rich plasma; intra-articular. |
format | Online Article Text |
id | pubmed-6556911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | AOSIS |
record_format | MEDLINE/PubMed |
spelling | pubmed-65569112019-06-14 Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis Smit, Yolandi Marais, Hendrik J. Thompson, Peter N. Mahne, Arnold T. Goddard, Amelia J S Afr Vet Assoc Original Research Osteoarthritis is a common cause of lameness in horses, resulting in poor performance. Intra-articular platelet-rich plasma can deliver a collection of bioactive molecules, such as autologous growth factors and proteins involved in the quality of tissue repair. Horses (n=5) with osteoarthritis affecting antebrachiocarpal, middle carpal or metacarpophalangeal joints, and horses (n=5) without osteoarthritis of the corresponding joints (radiographically free of osteoarthritis), were used for the production of platelet-rich plasma which was subsequently injected into selected joints. Clinical and synovial fluid changes after intra-articular injection of platelet-rich plasma as well as synovial platelet-derived growth factor-BB and transforming growth factor-beta 1 concentration changes were evaluated in these joints and compared between normal joints and joints with osteoarthritis. A gravity filtration system produced a moderately concentrated platelet-rich plasma, representing a 4.7-fold increase in baseline platelet concentration. The synovial effusion score was significantly different between the control joints and joints with osteoarthritis on Day 0 with a higher score in the group with osteoarthritis. Within the control group, the synovial effusion score was significantly higher on Days 1 and 2 compared to Day 0. For both groups, the synovial fluid nucleated cell count, predominantly intact neutrophils, was significantly increased on Days 1 and 2, with no significant difference between groups. The mean synovial platelet-derived growth factor-BB and transforming growth factor-beta 1 concentrations were increased for both groups but significantly lowered in the group with osteoarthritis on Day 1 compared to normal joints. Concentrations for platelet-derived growth factor-BB remained unchanged on Day 5, compared to Day 1, with no significant difference between groups. In conclusion, intra-articular treatment with platelet-rich plasma resulted in increased synovial growth factor concentrations in joints but with lower concentrations in joints with osteoarthritis. A transient inflammatory reaction was seen both clinically as an increase in synovial effusion and cytologically in both normal joints and joints with osteoarthritis. KEYWORDS: horse; osteoarthritis; platelet-rich plasma; intra-articular. AOSIS 2019-05-23 /pmc/articles/PMC6556911/ /pubmed/31170778 http://dx.doi.org/10.4102/jsava.v90i0.1721 Text en © 2019. The Authors https://creativecommons.org/licenses/by/4.0/ Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License. |
spellingShingle | Original Research Smit, Yolandi Marais, Hendrik J. Thompson, Peter N. Mahne, Arnold T. Goddard, Amelia Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis |
title | Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis |
title_full | Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis |
title_fullStr | Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis |
title_full_unstemmed | Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis |
title_short | Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis |
title_sort | clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556911/ https://www.ncbi.nlm.nih.gov/pubmed/31170778 http://dx.doi.org/10.4102/jsava.v90i0.1721 |
work_keys_str_mv | AT smityolandi clinicalfindingssynovialfluidcytologyandgrowthfactorconcentrationsafterintraarticularuseofaplateletrichproductinhorseswithosteoarthritis AT maraishendrikj clinicalfindingssynovialfluidcytologyandgrowthfactorconcentrationsafterintraarticularuseofaplateletrichproductinhorseswithosteoarthritis AT thompsonpetern clinicalfindingssynovialfluidcytologyandgrowthfactorconcentrationsafterintraarticularuseofaplateletrichproductinhorseswithosteoarthritis AT mahnearnoldt clinicalfindingssynovialfluidcytologyandgrowthfactorconcentrationsafterintraarticularuseofaplateletrichproductinhorseswithosteoarthritis AT goddardamelia clinicalfindingssynovialfluidcytologyandgrowthfactorconcentrationsafterintraarticularuseofaplateletrichproductinhorseswithosteoarthritis |